FAQ: Izotropic's IzoView Breast CT Imaging System - Next-Generation Breast Cancer Detection Technology
Summary
Izotropic Corporation has unveiled its IzoView Breast CT Imaging System, a revolutionary platform that transforms breast cancer screening by providing true 360-degree 3D visualization without compression discomfort. This technology overcomes limitations of traditional mammography, offering clearer detection in dense breast tissue with rapid scan times and radiation levels comparable to conventional methods.
What is the IzoView Breast CT Imaging System?
The IzoView Breast CT Imaging System is Izotropic Corporation’s flagship technology for breast cancer screening that provides true 360-degree, 3D visualization without compression discomfort. It represents a next-generation approach designed to overcome limitations of traditional mammography.
How does IzoView differ from traditional mammography?
Unlike compression-based 2D imaging used in traditional mammography, IzoView delivers true 360-degree, 3D visualization without discomfort. It provides clearer detection especially in dense breast tissue, which often obscures lesions in standard scans.
What are the key technical advantages of the IzoView system?
The system features a rapid 10-second scan time, high spatial resolution surpassing MRI, and radiation levels comparable to conventional mammography. It also has a self-shielding design that eliminates the need for facility retrofits.
Why is this technology significant for breast cancer detection?
IzoView addresses long-standing limitations of traditional mammography by enabling clearer detection in dense breast tissue and providing 3D visualization without compression discomfort. This enhances patient safety and experience while streamlining diagnosis.
What makes IzoView a scalable platform for healthcare providers?
Built as a scalable platform, IzoView supports future software-driven clinical applications from screening to treatment monitoring, maximizing ROI for healthcare providers. Its design expands accessibility across diverse imaging environments.
Who developed the IzoView technology?
Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) developed the IzoView Breast CT Imaging System as their flagship technology for transforming breast cancer screening.
Where can I find more information about Izotropic Corporation?
More information about Izotropic can be found on its website at izocorp.com and by reviewing its profile on SEDAR at sedarplus.ca.
How does IzoView benefit patients during the screening process?
IzoView eliminates the discomfort of compression-based imaging while providing clearer detection capabilities. The rapid 10-second scan time and comparable radiation levels to conventional mammography enhance both patient safety and experience.
What are the investment-related updates available for Izotropic?
The latest news and updates relating to IZOZF are available in the company’s newsroom at https://ibn.fm/IZOZF for investors seeking current information.
This story is based on an article that was registered on the blockchain. The original source content used for this article is located at InvestorBrandNetwork (IBN)
Article Control ID: 257095